Exelixis Financial Statements (EXEL)
|
|
|
|
Report date
|
|
|
18.02.2022 |
07.02.2023 |
06.02.2024 |
11.02.2025 |
10.02.2026 |
|
05.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 435 |
1 611 |
1 830 |
2 169 |
2 320 |
|
2 375 |
|
Operating Income, bln rub |
|
|
286.7 |
201.5 |
170.9 |
604.6 |
872.2 |
|
936.7 |
|
EBITDA, bln rub |
? |
|
300.3 |
222.4 |
196.6 |
718.8 |
921.8 |
|
991.8 |
|
Net profit, bln rub |
? |
|
231.1 |
182.3 |
207.8 |
521.3 |
782.6 |
|
833.4 |
|
|
OCF, bln rub |
? |
|
400.8 |
362.6 |
333.3 |
700.0 |
884.3 |
|
924.7 |
|
CAPEX, bln rub |
? |
|
64.2 |
138.5 |
163.0 |
66.2 |
39.9 |
|
6.23 |
|
FCF, bln rub |
? |
|
336.6 |
224.2 |
170.4 |
633.8 |
844.3 |
|
918.4 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 095 |
1 352 |
1 587 |
1 488 |
1 364 |
|
1 374 |
|
Cost of production, bln rub |
|
|
52.9 |
57.9 |
72.5 |
76.2 |
83.7 |
|
64.5 |
|
R&D, bln rub |
|
|
693.7 |
891.8 |
1 044 |
910.4 |
825.0 |
|
599.4 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
2 616 |
3 071 |
2 942 |
2 948 |
2 844 |
|
2 594 |
|
Net Assets, bln rub |
? |
|
2 211 |
2 488 |
2 264 |
2 244 |
2 161 |
|
1 936 |
|
Debt, bln rub |
|
|
51.3 |
190.2 |
189.9 |
190.8 |
173.0 |
|
169.5 |
|
Cash, bln rub |
|
|
1 467 |
1 308 |
995.3 |
1 111 |
1 059 |
|
777.2 |
|
Net debt, bln rub |
|
|
-1 416 |
-1 118 |
-805.4 |
-920.5 |
-886.1 |
|
-607.7 |
|
|
Ordinary share price, rub |
|
|
18.3 |
|
|
34.0 |
43.6 |
|
46.1 |
|
Number of ordinary shares, mln |
|
|
314.9 |
321.5 |
318.2 |
290.0 |
271.6 |
|
258.3 |
|
|
Market cap, bln rub |
|
|
5 756 |
0 |
0 |
9 852 |
11 835 |
|
11 922 |
|
EV, bln rub |
? |
|
4 340 |
-1 118 |
-805 |
8 932 |
10 949 |
|
11 314 |
|
Book value, bln rub |
|
|
2 147 |
2 425 |
2 200 |
2 181 |
2 098 |
|
1 872 |
|
|
EPS, rub |
? |
|
0.73 |
0.57 |
0.65 |
1.80 |
2.88 |
|
3.23 |
|
FCF/share, rub |
|
|
1.07 |
0.70 |
0.54 |
2.19 |
3.11 |
|
3.56 |
|
BV/share, rub |
|
|
6.82 |
7.54 |
6.92 |
7.52 |
7.72 |
|
7.25 |
|
|
EBITDA margin, % |
? |
|
20.9% |
13.8% |
10.7% |
33.1% |
39.7% |
|
41.8% |
|
Net margin, % |
? |
|
16.1% |
11.3% |
11.4% |
24.0% |
33.7% |
|
35.1% |
|
FCF yield, % |
? |
|
5.85% |
|
|
6.43% |
7.13% |
|
7.70% |
|
ROE, % |
? |
|
10.5% |
7.33% |
9.18% |
23.2% |
36.2% |
|
43.1% |
|
ROA, % |
? |
|
8.83% |
5.93% |
7.06% |
17.7% |
27.5% |
|
32.1% |
|
|
P/E |
? |
|
24.9 |
0.00 |
0.00 |
18.9 |
15.1 |
|
14.3 |
|
P/FCF |
|
|
17.1 |
0.00 |
0.00 |
15.5 |
14.0 |
|
13.0 |
|
P/S |
? |
|
4.01 |
0.00 |
0.00 |
4.54 |
5.10 |
|
5.02 |
|
P/BV |
? |
|
2.68 |
0.00 |
0.00 |
4.52 |
5.64 |
|
6.37 |
|
EV/EBITDA |
? |
|
14.5 |
-5.03 |
-4.10 |
12.4 |
11.9 |
|
11.4 |
|
Debt/EBITDA |
|
|
-4.71 |
-5.03 |
-4.10 |
-1.28 |
-0.96 |
|
-0.61 |
|
|
R&D/CAPEX, % |
|
|
1 080% |
644.1% |
640.7% |
1 376% |
2 066% |
|
9 626% |
|
|
CAPEX/Revenue, % |
|
|
4.48% |
8.59% |
8.90% |
3.05% |
1.72% |
|
0.26% |
|
| Exelixis shareholders |
